2020-11-25 2021-11-30 false No description of principal activity Acting Office - Tax and Accounts 1.0 13043112 bus:FullAccounts 2020-11-25 2021-11-30 13043112 bus:Micro-entities 2020-11-25 2021-11-30 13043112 bus:AuditExempt-NoAccountantsReport 2020-11-25 2021-11-30 13043112 bus:SmallCompaniesRegimeForAccounts 2020-11-25 2021-11-30 13043112 bus:PrivateLimitedCompanyLtd 2020-11-25 2021-11-30 13043112 2020-11-25 2021-11-30 13043112 2021-11-30 13043112 bus:RegisteredOffice 2020-11-25 2021-11-30 13043112 core:WithinOneYear 2021-11-30 13043112 core:AfterOneYear 2021-11-30 13043112 2019-11-25 13043112 bus:Director1 2020-11-25 2021-11-30 13043112 bus:Director1 2021-11-30 13043112 bus:CompanySecretary1 2020-11-25 2021-11-30 13043112 bus:LeadAgentIfApplicable 2020-11-25 2021-11-30 13043112 2020-11-24 13043112 core:CostValuation core:Non-currentFinancialInstruments 2021-11-30 13043112 core:CostValuation core:Non-currentFinancialInstruments 2020-11-24 13043112 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2021-11-30 13043112 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2021-11-30 13043112 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2021-11-30 13043112 core:Non-currentFinancialInstruments 2021-11-30 13043112 core:Non-currentFinancialInstruments 2020-11-24 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13043112
England and Wales

 

 

 


Report of the Director and Unaudited Financial Statements

for the period ended 30 November 2021

for

MB PHARMA SUPPORT SERVICES LTD

 
 
 
£
2021
£
Current assets 53,488 
Creditors: amount falling due within one year (22,634)
Net current assets 30,854 
Total assets less current liabilities 30,854 
Net assets 30,854 
 
Capital and reserves 30,854 
 
  1. For the period ended 30 November 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the companies act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


----------------------------------
Mary Louise Bermingham
Director

Date approved: 12 August 2022
1
Statutory Information
MB PHARMA SUPPORT SERVICES LTD is a private limited company, limited by shares, domiciled in England and Wales, registration number 13043112, registration address 4 Green Tiles, Denham, Uxbridge, UB9 5HX, United Kingdom.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
Going Concern
The financial statements have been prepared on a going concern basis. The company's ongoing activities are dependent upon the continued support of the director who has undertaken to provide such support for the foreseeable future. If the going concern basis were not appropriate, adjustments would have to be made to reduce the value of assets to their recoverable amount, to provide for any further liabilities that may arise and to reclassify fixed assets as current assets and long term liabilities as current liabilities.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Dividends
Proposed dividends are only included as liabilities in the financial statements when their payment has been approved by the shareholders prior to the balance sheet date.
2.

Average number of employees

Average number of employees during the period was 1 .
2